LXP-7

General Information


DRACP ID  DRACP06033

Peptide Name   LXP-7

Sequence  RAGLQFPVGKLLKKLLKKLLK

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C115H207N31O23

Absent amino acids  CDEHIMNSTWY

Common amino acids  L

Mass  274904

Pl  12.1

Basic residues  7

Acidic residues  0

Hydrophobic residues  10

Net charge  7

Boman Index  -861

Hydrophobicity  7.62

Aliphatic Index  148.57

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN114605517A

Patent Title  Polypeptide LXP-7 with broad-spectrum anticancer effect and application thereof

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.